Promising data with TCR T-cell therapies has been witnessed lately in solid tumors. SITC 2021 included many novel approaches to improve the functionality of CAR-T and TCR magic bullets and enhance their efficacy/safety by reprogramming the tumor microenvironment. SmartAnalyst selected some interesting presentations to understand the challenges in development in solid tumors.

Click here to learn more: SITC Highlights